Biofy fights antibiotic resistance with Oracle Cloud Infrastructure: featured in Silicon

Biofy Technologies once again gains prominence in the press, this time on the portal Silicon, one of the leading sources of news and analysis on technology, innovation, and digital transformation worldwide. Founded in 1998 by a group of journalists with the aim of creating an accessible and reliable technology publication, B!T Magazine covers topics such as software, hardware, Big Data, Cloud, Business Intelligence, Mobile, and Business, primarily focusing on the B2B audience.

Over the years, the magazine has gained recognition for its impartiality and editorial quality, reaching around 12 million readers in Europe, Latin America, and the United States today, thanks to its integration with the media group Netmediaeuropa, S.A. This wide reach makes B!T Magazine an influential communication vehicle in the technology segment.

Biofy Technologies once again gains prominence in the press, this time on the portal Silicon, one of the leading sources of news and analysis on technology, innovation, and digital transformation worldwide. Founded in 1998 by a group of journalists with the aim of creating an accessible and reliable technology publication, B!T Magazine covers topics such as software, hardware, Big Data, Cloud, Business Intelligence, Mobile, and Business, primarily focusing on the B2B audience.

Over the years, the magazine has gained recognition for its impartiality and editorial quality, reaching around 12 million readers in Europe, Latin America, and the United States today, thanks to its integration with the media group Netmediaeuropa, S.A. This wide reach makes B!T Magazine an influential communication vehicle in the technology segment.

Biofy and Oracle Cloud in the fight against antibiotic resistance

In the B!T Magazine report, Biofy is highlighted for its innovative technology that combines artificial intelligence and genetic sequencing to accelerate diagnostics and provide personalized treatments in fighting resistant bacterial infections.

The Abby Recommender system, developed by Biofy, uses Oracle Cloud Infrastructure (OCI) to process large volumes of genomic data quickly and securely. This solution enables the delivery of results in hours instead of days, representing a crucial advancement for hospitals and laboratories.

Cutting-edge technology for rapid and accurate diagnostics

The report notes that Biofy's proprietary system, the Abby Recommender, uses state-of-the-art genetic sequencing combined with artificial intelligence to identify the causative agent of the bacterial infection and recommend the most effective antibiotic, even in the face of resistance from certain microorganisms.

As highlighted by Silicon:

“Biofy's platform processes genomic data in the cloud, using artificial intelligence to quickly analyze results and recommend personalized treatments, drastically reducing diagnostic time.”

This agility is crucial in hospital settings where every minute counts in saving lives.

The fundamental role of Oracle Cloud Infrastructure

The article emphasizes the use of Oracle Cloud Infrastructure (OCI) as a strategic element that provides Biofy with the capacity to process large volumes of data at high speed, security, and scalability, ensuring the performance necessary for the operation of Abby Recommender on a national scale.

Partnerships that strengthen innovation

Biofy participates in the Oracle for Startups program, which supports the development of innovative solutions with cutting-edge technological infrastructure, in addition to integrating the NVIDIA Inception Program, focused on disruptive startups in artificial intelligence.

These partnerships reinforce Biofy's commitment to bringing innovation and advanced technology to combat antimicrobial resistance, contributing to public health in Brazil.

Our commitment

At Biofy, our mission is clear: to use technology to transform human, animal, and environmental health, tackling critical challenges such as bacterial resistance. With solutions that combine biotechnology and artificial intelligence, we aim to accelerate diagnostics, increase treatment efficiency, and save lives.

📎 Read the full article from Silicon:

👉 Biofy fights antibiotic resistance with Oracle Cloud Infrastructure